Previous Page  17 / 139 Next Page
Information
Show Menu
Previous Page 17 / 139 Next Page
Page Background

M

énétrier

s

disease

associated

with

gastric

adenocarcinoma

in

a

child

imaging

aspect

R

ev

A

ssoc

M

ed

B

ras

2016; 62(6):485-489

489

-dependent. The findings are wall thickening, usually

diffuse, or a hypoechoic mass with echogenic center or

“pseudo-kidney” sign.

16

CT is the method of choice because, in addition to

identifying the primary tumor, it assesses the signs of lo-

cal invasion, regional and distant lymph node involvement,

as well as metastases. Imaging findings vary depending on

the type and grade of the tumor, including diffuse or seg-

mental thickening with intravenous contrast enhancement,

masses, ulceration, and loss of distensibility.

16,19

UGE is the method of choice for definitive diagnosis,

because it is more sensitive and allows biopsies to be per-

formed for histopathologic analysis.

16

Endoscopic ultrasonography is currently the best

method for assessing the primary tumor as well as eval-

uating the local extent of the tumor and the presence of

compromised regional lymph nodes.

19

Recent studies have demonstrated the role of MRI in

the diagnosis of early gastric carcinomas that are not seen

on other imaging tests.

20

The rarity of gastric cancer in children makes this di-

agnosis a very remote possibility among pediatricians.

Also, the initial nonspecific gastrointestinal symptoms

eventually lead to a significant delay in diagnosis, result-

ing in late start of appropriate treatment. As a result, gas-

tric adenocarcinomas in pediatric patients have more ad-

vanced stage at diagnosis, presenting worse prognosis

compared to adults.

13,14

Treatment of GAC in children is usually based on

methods used in adults, due to the rarity of this disease

in pediatric populations, and therefore there is no stan-

dard treatment model.

13,15

R

eferences

1. Coffey RJ Jr, Tanksley J. Pierre Ménétrier and his disease. Trans Am Clin

Climatol Assoc. 2012; 123:126-34.

2.

Friedman J, Platnick J, Farruggia S, Khilko N, Mody N, Tyshkov M. Best

cases from the AFIP. Ménétrier disease. RadioGraphics, 2009; 29(1):297-

301.

3.

Fiori R, Velari L, Di Vito L, Della Gatta F, Bianchi M, Capurso L, et al.

Ménétrier’s disease diagnosed by enteroclysis CT: a case report and review

of the literature. Abdom Imaging. 2011; 36(6):689-93.

4. Narumi S, Omori T, Mitamura K, Yamashita Y, Nakao A, Cho H.

Correspondence between computed tomography and endoscopy inMénétrier’s

disease. Pediatr Int. 2008; 50(2):245-7.

5.

Sferra TJ, Pawel BR, Qualman SJ, Li BU. Ménétrier disease of childhood: role

cytomegalovirus and transforming growth factor alpha. J Pediatr. 1996;

128(2):213-9.

6.

Hillman MM, Meinarde LL, Furnes RA, Daruich ML, Riva V, Cuestas E.

[Protein losing gastroenteropathy and possible relationship to

cytomegalovirus infection. Ménétrier disease in a child]. Arch Argent Pediatr.

2013; 111(5):446-9.

7.

Lambrecht NW. Ménétrier’s disease of the stomach: a clinical challenge.

Curr Gastroenterol Rep. 2011; 13(6):513-7.

8. Coffey RJ, Washington MK, Corless CL, Heinrich MC. Ménétrier disease

and gastrointestinal stromal tumors: hyperproliferative disorders of the

stomach. J Clin Invest. 2007; 117(1):70-80.

9.

Rothenberg M, Pai R, Stuart K. Successful use of octreotide to treat

Ménétrier’s disease: a rare cause of abdominal pain, weight loss, edema, and

hypoalbuminemia. Dig Dis Sci. 2009; 54(7):1403-7.

10. Takaya J, Kawamura Y, Kino M, Kawashima Y, Yamamoto A, Kobayashi Y.

Ménétrier’s disease evaluated serially by abdominal ultrasonography. Pediatr

Radiol. 1997; 27(2):178-80.

11.

Palmer WE, Bloch SM, Chew FS. Ménétrier disease. AJR Am J Roentgenol.

1992; 158(1):62.

12.

Songür Y, Okai T, Watanabe H, Motoo Y, Sawabu N. Endosonographic

evaluation of giant gastric folds. Gastrointest Endosc. 1995; 41(5):468-74.

13.

Subbiah V, Varadhachary G, Herzog CE, Huh WW. Gastric adenocarcinoma

in children and adolescents. Pediatr Blood Cancer. 2011; 57(3):524-7.

14. Al-Hussaini A, AlGhamdi S, Alsaaran R, Al-Kasim F, Habib Z, Ourfali N.

Gastric adenocarcinoma presenting with gastric outlet obstruction in a

child. Case Rep Gastrointest Med. 2014; 2014(2014):527471.

15.

Emir S, Karakurt N, Karaku

ş

E,

Ş

enel E, Kırsaçlıo

ğ

lu C, Demir HA, et al.

Alpha-fetoprotein-producing hepatoid gastric adenocarcinoma in a child

presenting with spontaneous gastricperforation. Turk J Pediatr. 2014;

56(1):88-91.

16. D’Ippolito G, Caldana RP. Gastrointestinal. Rio de Janeiro: Elsevier; 2011. 768p.

17. ShindohN, Nakagawa T, Ozaki Y, Kyogoku S, Sumi Y, Katayama H. Overlooked

gastric carcinoma: pitfalls in upper gastrointestinal radiology. Radiology. 2000;

217(2):409-14.

18.

Horton KM, Fishman EK. Current role of CT in imaging of the stomach.

Radiographics. 2003; 23(1):75-87.

19.

Habermann CR, Weiss F, Riecken R, Honarpisheh H, Bohnacker S, Staedtler

C, et al. Preoperative staging of gastric adenocarcinoma: comparison of

helical CT and endoscopic US. Radiology. 2004; 230(2):465-71.

20. Yamada I, Saito N, Takeshita K, Yoshino N, Tetsumura A, Kumagai J, et al.

Early gastric carcinoma: evaluation with high-spatial resolution MR imaging

in vitro. Radiology. 2001; 220(1):115-21.